180 related articles for article (PubMed ID: 12853750)
21. Characteristics and survival of AIDS patients with hepatitis C: the Brazilian National Cohort of 1995-1996.
Marins JR; Barros MB; Machado H; Chen S; Jamal LF; Hearst N
AIDS; 2005 Oct; 19 Suppl 4():S27-30. PubMed ID: 16249650
[TBL] [Abstract][Full Text] [Related]
22. [Survival analysis on AIDS patients undergoing antiretroviral treatment, Liangshan prefecture, Sichuan province].
Zhang G; Gong Y; Wang Q; Liao Q; Yu G; Wang J; Wang K; Yin B; Xiao L; Li Y; Liu Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Dec; 35(12):1329-32. PubMed ID: 25623448
[TBL] [Abstract][Full Text] [Related]
23. Inequalities in HAART uptake and differential survival according to exposure category in Rio de Janeiro, Brazil.
Lima TA; Beyrer C; Golub JE; Mota JCD; Malta MS; Silva CMFPD; Bastos FI
Cad Saude Publica; 2018 Aug; 34(8):e00009617. PubMed ID: 30133651
[TBL] [Abstract][Full Text] [Related]
24. AIDS incidence and survival in a hospital-based cohort of asymptomatic HIV seropositive patients in São Paulo, Brazil.
Fonseca LA; Reingold AL; Casseb JR; Brigido LF; Duarte AJ
Int J Epidemiol; 1999 Dec; 28(6):1156-60. PubMed ID: 10661662
[TBL] [Abstract][Full Text] [Related]
25. The first one hundred AIDS cases in Hong Kong.
Lee SS; Lo YC; Wong KH
Chin Med J (Engl); 1996 Jan; 109(1):70-6. PubMed ID: 8758375
[TBL] [Abstract][Full Text] [Related]
26. [Survival time and related influencing factors of AIDS patients in Liangshan prefecture, Sichuan province, during 2008-2013].
Deng L; Liu Z; Zhang S; Dou Z; Wang Q; Ma Y; Gong Y; Yu G; Wang J; Yu H; Miao F
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jun; 36(6):569-75. PubMed ID: 26564626
[TBL] [Abstract][Full Text] [Related]
27. [Survival analysis of HIV/AIDS patients with access to highly antiretroviral therapy in Ningbo during 2004-2015].
Zhang JH; Li HL; Shi HB; Jiang HB; Hong H; Dong HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Sep; 37(9):1262-1267. PubMed ID: 27655575
[No Abstract] [Full Text] [Related]
28. Profile of patients diagnosed with AIDS at age 60 and above in Brazil, from 1980 until June 2009, compared to those diagnosed at age 18 to 59.
Fonseca MO; Tupinambás U; Sousa AI; Baisley K; Greco DB; Rodrigues L
Braz J Infect Dis; 2012; 16(6):552-7. PubMed ID: 23158265
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with survival following secondary AIDS: 1988 to 1995.
Huang H; Chmiel JS; Detels R; Hoover DR; Muñoz A
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):495-504. PubMed ID: 9715847
[TBL] [Abstract][Full Text] [Related]
30. [Survival analysis on HIV/AIDS patients who began receiving antiretroviral therapy from 2005 to 2015 in Tianjin].
Guo Y; Zhou N; Zhao FN; Liu ZQ; Li L; Yu MH
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Aug; 40(8):936-940. PubMed ID: 31484257
[No Abstract] [Full Text] [Related]
31. Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality.
Hacker MA; Petersen ML; Enriquez M; Bastos FI
Rev Panam Salud Publica; 2004 Aug; 16(2):78-83. PubMed ID: 15357932
[TBL] [Abstract][Full Text] [Related]
32. Differential impact of combined antiretroviral therapy on the survival of italian patients with specific AIDS-defining illnesses.
Conti S; Masocco M; Pezzotti P; Toccaceli V; Vichi M; Boros S; Urciuoli R; Valdarchi C; Rezza G
J Acquir Immune Defic Syndr; 2000 Dec; 25(5):451-8. PubMed ID: 11141245
[TBL] [Abstract][Full Text] [Related]
33. Survival of adult AIDS patients in a reference hospital of a metropolitan area in Brazil.
Guerreiro MF; Kerr-Pontes LR; Mota RS; Franca MC; Tavora FF; Caminha I
Rev Saude Publica; 2002 Jun; 36(3):278-84. PubMed ID: 12131965
[TBL] [Abstract][Full Text] [Related]
34. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
35. Predictors of mortality among HIV-infected women in Kigali, Rwanda.
Lindan CP; Allen S; Serufilira A; Lifson AR; Van de Perre P; Chen-Rundle A; Batungwanayo J; Nsengumuremyi F; Bogaerts J; Hulley S
Ann Intern Med; 1992 Feb; 116(4):320-8. PubMed ID: 1733389
[TBL] [Abstract][Full Text] [Related]
36. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma.
Skiest DJ; Crosby C
AIDS; 2003 Aug; 17(12):1787-93. PubMed ID: 12891064
[TBL] [Abstract][Full Text] [Related]
37. The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l.
Coakley EP; Samore MH; Gillis JM; Hughes MD; Hammer SM
AIDS; 2000 Jun; 14(9):1147-53. PubMed ID: 10894278
[TBL] [Abstract][Full Text] [Related]
38. Survival after AIDS among Italian haemophiliacs with HIV infection. The Italian Group on Congenital Coagulopathies.
Ghirardini A; Puopolo M; Rossetti G; Mancuso G; Perugini L; Piseddu G; Chiarotti F
AIDS; 1995 Dec; 9(12):1351-6. PubMed ID: 8605055
[TBL] [Abstract][Full Text] [Related]
39. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco.
McFarland W; Chen S; Hsu L; Schwarcz S; Katz M
J Acquir Immune Defic Syndr; 2003 May; 33(1):96-103. PubMed ID: 12792361
[TBL] [Abstract][Full Text] [Related]
40. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
